Press Release for the Audited Consolidated and Standalone Financial Results for the quarter and financial year ended March 31, 2026
TATACHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Tata Chemicals reported Q4FY26 consolidated revenue of ₹3,438 Cr (down 2% YoY) and EBITDA of ₹274 Cr (vs ₹327 Cr in Q4FY25), impacted by subdued soda ash pricing globally. The company took an exceptional impairment charge of ₹1,837 Cr for goodwill in US operations and ₹159 Cr deferred tax asset write-off amid challenging export market conditions. Consolidated PAT (before exceptional items and NCI) turned negative at ₹(279) Cr vs ₹(12) Cr in Q4FY25. Net debt stood at ₹5,961 Cr. Standalone performance was more resilient with 9% revenue growth to ₹4,831 Cr and 17% EBITDA growth to ₹954 Cr, supported by higher India volumes and cost controls. The board recommended a dividend of ₹11 per share. The company completed the Novabay Pte. Limited acquisition in March 2026 and approved a ₹100 Cr investment to debottleneck salt capacity at Mithapur. Non-soda ash revenue grew 14% YoY.
The large goodwill impairment in US and persistent pricing pressure across geographies signal near-term headwinds for consolidated profitability, though the resilient standalone performance and dividend provide some support. The strong debt position needs monitoring.